Back
Compass Therapeutics, Inc. Stock Predictions
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.
Buy
61
CMPX
Compass Therapeutics, Inc.
Last Price:
$5.18
Seasonality Move:
-8.55%
7 Day Trial
ALL ACCESS PASS
$
7
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.Compass Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 60.3% based on the past 4 years of stock performance.
-
Compass Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Compass Therapeutics, Inc. Stock Undervalued?The current Compass Therapeutics, Inc. [CMPX] share price is $5.37. The Score for CMPX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
CMPX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Compass Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 60.3% based on the past 4 years of stock performance.
Compass Therapeutics, Inc. Stock Rating
Buy
61
Compass Therapeutics, Inc. (CMPX)
is a Buy
Is Compass Therapeutics, Inc. overpriced?
-
Compass Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Compass Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
compasstherapeutics.com
52-Week Data
52-Week High:
5.86
52-Week Low:
1.33
Prediction Charts
Market Cap:
920.4M
Price in USD:
5.37
Volume:
1.8M
Beta:
1.27
Technical Analysis
SMA50:
4.76
SMA100:
4.13
SMA200:
3.22
52-Wk Change:
270.34%
Stock Predictions
-
Is Compass Therapeutics, Inc. stock public?Yes, Compass Therapeutics, Inc. is a publicly traded company.
-
What is the Compass Therapeutics, Inc. stock quote today?The Compass Therapeutics, Inc. stock price is 5.37 USD today.
-
How to buy Compass Therapeutics, Inc. stock online?You can buy Compass Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-10 | 5.17 | 5.25 | 5.36 | 5.10 |
| Dec-11 | 5.25 | 5.39 | 5.44 | 5.17 |
| Dec-12 | 5.38 | 5.16 | 5.43 | 5.15 |
| Dec-15 | 5.18 | 5.08 | 5.28 | 5.05 |
| Dec-16 | 5.01 | 5.24 | 5.32 | 5.00 |
| Dec-17 | 5.25 | 4.96 | 5.30 | 4.83 |
| Dec-18 | 5.11 | 5.04 | 5.15 | 4.95 |
| Dec-19 | 5.07 | 4.99 | 5.19 | 4.95 |
| Dec-22 | 5.03 | 5.14 | 5.27 | 5.00 |
| Dec-24 | 5.18 | 5.14 | 5.20 | 5.03 |
| Dec-26 | 5.14 | 5.17 | 5.20 | 5.05 |
| Dec-29 | 5.10 | 5.15 | 5.22 | 5.05 |
| Dec-30 | 5.22 | 5.38 | 5.39 | 5.06 |
| Dec-31 | 5.37 | 5.37 | 5.45 | 5.19 |
Compass Therapeutics, Inc. Earnings
Compass Therapeutics, Inc. Earnings Report: Per Share Compass Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Compass Therapeutics, Inc. Forecast Revenue Growth
Compass Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Compass Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $0.05 per share.
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.